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Obesity and diabetesA novel family of 2Fe–2S proteins, the NEET family, was discovered during the last decade in numerous organ-
isms, including archea, bacteria, algae, plant and human; suggesting an evolutionary-conserved function, poten-
tially mediated by their CDGSH Iron–Sulfur Domain. In human, three NEET members encoded by the CISD1–3
genes were identiﬁed. The structures of CISD1 (mitoNEET, mNT), CISD2 (NAF-1), and the plant At-NEET uncov-
ered a homodimer with a unique “NEET fold”, as well as two distinct domains: a beta-cap and a 2Fe–2S cluster-
binding domain. The 2Fe–2S clusters of NEET proteins were found to be coordinated by a novel 3Cys:1His struc-
ture that is relatively labile compared to other 2Fe–2S proteins and is the reason of the NEETs' clusters could be
transferred to apo-acceptor protein(s) ormitochondria. Positioned at the protein surface, theNEET's 2Fe–2S's co-
ordinating His is exposed to protonation upon changes in its environment, potentially suggesting a sensing func-
tion for this residue. Studies in differentmodel systems demonstrated a role for NAF-1 andmNT in the regulation
of cellular iron, calcium and ROS homeostasis, and uncovered a key role for NEET proteins in critical processes,
such as cancer cell proliferation and tumor growth, lipid and glucose homeostasis in obesity and diabetes, control
of autophagy, longevity in mice, and senescence in plants. Abnormal regulation of NEET proteins was conse-
quently found to result inmultiple health conditions, and aberrant splicing of NAF-1 was found to be a causative
of the neurological genetic disorderWolfram Syndrome 2. Here we review the discovery of NEET proteins, their
structural, biochemical and biophysical characterization, and their most recent structure–function analyses. We
additionally highlight future avenues of research focused on NEET proteins and propose an essential role for
NEETs in health and disease. This article is part of a Special Issue entitled: Fe/S proteins: Analysis, structure, func-
tion, biogenesis and diseases.
© 2014 Elsevier B.V. All rights reserved.1. Preface: Fe–S proteins —major players in health and disease
Performing a wide-range of biological processes essential to sustain
life, iron–sulfur proteins are highly conserved throughout evolution.
Most commonly, they harbor 2Fe–2S and/or 4Fe–4S clusters,which par-
tially mediate these proteins' multiple functions [1,2]. The redoxteins: Analysis, structure, func-potential of these Fe–S clusters varies from −500 mV to +300 mV
(SHE), making them excellent electron donors/acceptors capable of
driving different fundamental chemical reactions involved in processes
such as respiration, photosynthesis and nitrogen ﬁxation [3]. Indeed in
these essential processes the most well established function of Fe–S
containing proteins is to serve as electron transfer (ET) proteins. How-
ever, in the last decade new evidence has emerged showing that the
Fe–S clusters of numerous Fe–S proteins have additional functions,
such as sensing of iron or oxygen, as well as substrate binding/catalysis
and gene expression regulation [2,3].
The biogenesis of iron–sulfur clusters is a multi-step process invol-
ving complex protein machinery [3–6]. In eukaryotes, more than 17
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the cytosol, mitochondria [8], and chloroplasts. Fe–S biogenesis proteins
facilitate the assembly of the cluster as well as its transfer to inactivate
Fe–S holo-proteins [5,6]. In recent years, an increasing number of
genetic-based human diseases have been attributed to mutations in
Fe–S proteins, many of which are proteins shown to be associated
with dysfunction of the Fe–S cluster biogenesis pathway. Examples in-
clude Friedreich's ataxia, glutaredoxin 5-deﬁcient sideroblastic anemia,
ISCU myopathy, and ABCB7 sideroblastic anemia/ataxia syndrome
[9–13]. Among the genetic diseases directly associated with a gene
encoding a 2Fe–2S protein is Wolfram Syndrome 2 (WFS-2) [14]. This
neurological disorder results from a mutation in the CISD2 gene leading
to loss of the 2Fe–2S cluster of the NAF-1 (nutrient-deprivation autoph-
agy factor-1, synonyms: ERIS, Miner1, CISD2, Noxp70) protein, a mem-
ber of the recently discovered NEET protein family [8,9,15,16].
2. The discovery of NEET proteins and their initial characterization
2.1. The NEET family of proteins
MitoNEET (mNT), the founding member of the NEET family of pro-
teins, was discovered as a mitochondrial protein that binds the anti-
type 2 diabetes drug, pioglitazone [17]. With the completion of a draft
human genome sequence it became evident that mNT in humans be-
longs to a family of three mNT-like human proteins (18). The initial
names given to the mNT paralogs were Miner1 and Miner2 meaning
mitoNEET related 1 and mitoNEET related 2, respectively. Miner1 has
also been named ERIS, Noxp70 and NAF-1 due to its association with
disease, neural development and autophagy [14,19]. We here refer to
the second member of the NEET family as NAF-1. Upon identifying the
three human NEET family members, it became evident that all three
members share a 39 amino acid stretch called the CDGSH domain [18]
. The three human NEET proteins are encoded by the CISD1, CISD2 and
CISD3 genes inwhich CISD stands for CDGSH Iron–SulfurDomain.With-
in the CDGSH domain is a 16 amino acid stretch that was later shown in
the mNT crystal structure to contain the four ligands of the Fe–S cluster
(Fig. 1) [20]. Using UV–vis andMS analysis, we demonstrated that mNTFig. 1. Human NEET protein alignments and UV–vis spectra. (A) Amino acids conserved in hum
yellow. The 16 amino acid cluster binding domains are boxed inmagenta. Note thatMiner2 has
membrane domains of mitoNEET and NAF-1 are highlighted by a blue box. (B) UV–vis spectra
region which are ligand to metal charge transfer bands reﬂecting the presence of the same typharbored a labile and redox active 2Fe–2S cluster [21]. As the UV–vis
spectra of NAF-1 and Miner2 are very similar to that of mNT, we de-
duced that they similarly contain 2Fe–2S clusters (Fig. 1). This was
later conﬁrmed for NAF-1 by the determination of its crystal struc-
ture [21]. It should be noted here that Miner2 encoded by the CISD3
gene is the least characterized member of this gene family and thus it
is described in less detail in this review.
MitoNEET was found to be localized to themitochondria as original-
ly predicted [17]. In addition, it was shown to be tethered to the outer
mitochondrialmembrane (OMM)with themajor part of the protein, in-
cluding its C-terminal domain, located in the cytosol [18]. In contrast,
GFP-fused NAF-1 was shown to be more diffused in its localization
[18]. Its distribution was more indicative of association with the endo-
plasmic reticulum (ER); one of its earlier names was ERIS meaning ER
Iron–Sulfur protein [14]. Other studies, however, showed its association
withmitochondria [22]. Most recently, in a detailed subcellular localiza-
tion study, NAF-1 was shown to be localized to the mitochondria-
associated membrane (MAM) that connects the ER to the OMM [16],
perhaps unifying the previous disparate localization studies. Miner2
was shown to localize (predominantly) to the mitochondria, although
details about its submitochondrial localization are not yet known [18].
Thus, all three members of the human NEET family are located on, or
in proximity to, the mitochondrial membrane with mNT and NAF-1
containing a single transmembrane helix for anchoring.
2.2. Identifying the 2Fe–2S cluster of NEET proteins
Identiﬁcation and characterization of the ion metals that comprise
the NEET proteins' CDGSH domain required high amounts of puriﬁed
protein. In order to achieve that, the transmembrane N-terminal helix
was removed and a His-tag was added to mNT [20], and NAF-1 [21].
When puriﬁed from Escherichia coli cells, the recombinant His-tagged
truncated NEET proteins were red in color. As this color is indicative of
iron, the metal composition was measured. The isolated mNT protein
contained more iron than any other metals [18]. Using the isolated pro-
tein, wewere able to obtain UV–vis spectra and utilizemore biophysical
techniques to characterize the Fe state of this protein. The UV–visans are shown in gray. Amino acids that coordinate to the 2Fe–2S clusters are shown in
a repeat of the 16 amino acid 2Fe–2S cluster binding domain, underlined in pink. The trans-
of mitoNEET, NAF-1 and Miner2. Note the similarities of the peak positions in the visible
e of Fe–S clusters and the similarity of their coordinations.
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that of known iron–sulfur containing proteins, such as ferredoxin and
Rieske (see below), indicative of intact iron–sulfur clusters in the sam-
ples. Furthermore, reduction with a strong reducing agent, dithionite,
showed the expected spectral changes associated with the reduction
of an iron–sulfur cluster [20]. However, these observations alone did
not provide deﬁnitive evidence for the type of iron–sulfur cluster, e.g.
2Fe–2S or 4Fe–4S. The ﬁnding that the Fe–S cluster of mNT dissociated
at lower pH, allowed the determination of the mass of the protein prior
to and following the loss of its iron–sulfur cluster. Mass spectroscopy
(MS) allowed us to easily distinguish between holo- and apo-mNTmak-
ing thismeasurement less susceptible to the purity of the startingmate-
rial. A mixture of apo- and holo-mNT would therefore appear as two
separate peaks with distinct masses. The mass difference between the
apo- and holo-mitoNEET showed unambiguously that the cluster in
mNT is a 2Fe–2S cluster. These ﬁndings suggested that the 2Fe–2S clus-
ter of NEET proteins could be used for electron reduction/transfer in a
process that could be modulated by changing pH [20].
Replacement of the His87 with Gln (H87Q mutant) eliminated the
cluster and replacement of the His87 with Cys (H87C mutant) altered
the UV–vis spectrum and stabilized the 2Fe–2S cluster establishing
that His 87 is most likely the non-Cys ligand of the cluster (Fig. 2). In
the H87C mutant, the absorption peak positions in the visible range ofFig. 2. The 2Fe–2S cluster of NEET proteins is pH-labile. (A)MitoNEET cluster stability; the absorb
(WT) andmutantmNTproteins as a function of time at different pH. (a) Optical spectra ofWT (b
2Fe–2S cluster of mitoNEET at pH7.0 (purple) and 4.5 (blue)when comparedwith that of ferred
(black), D84N (green), and H87C (blue)mitoNEET at pH 6.0 as a function of time. Note that the
tantmitoNEET [20]. (B)Destabilization of NAF-1 2Fe–2S cluster: Similar tomNT, the stability of th
pH 5.5 (blue and orange, respectively). At pH 5.5, NAF-1's cluster is more stable thanmNT's clus
and NAF-1 mutant H114C (green and red, respectively) [23]. Buffers used in A and B are differthe spectrum were slightly shifted from the native as an expected con-
sequence of changing the ligation to the 2Fe–2S cluster (Fig. 2A); the Vis
absorption peaks are due to ligand tometal charge-transfer interactions.
His114 of NAF-1 is the equivalent of His87 of mNT and more recent
studies indicated similar optical absorbance changes and labile proper-
ties of NAF-1 and its H114C mutant (Fig. 2B) and [21,23].
As the lability of the 2Fe–2S clusters of NEET proteins is quite sensi-
tive to their environment, cluster stability measurements have become
one of the ﬁrst measures of interactions of NEET proteins with small
molecules and/or other proteins, as well as for the effect of mutations
on the cluster stability and dynamics (Fig. 2).
2.3. Structure of NEET proteins
2.3.1. Structures of human NEET proteins
Three crystal structures of the soluble region of mNT were reported
and in principal they were essentially identical [24–26]. Our group ob-
tained the crystals at neutral pH conditions under which mNT was
more stable. Multiwavelength anomalous diffraction (MAD) was uti-
lized to obtain model-independent phasing information for the three-
dimensional structure [24]. Concurrently, another group obtained and
presented the structure of mitoNEET [25], and shortly after the third
structure was published [26]. Surprisingly, the structure showed noance and stability of the Fe–S cluster of mitoNEETweremonitored at 458 nm inwild type
lack), D84N (green), H87C (blue), andH87Q (violet)mitoNEET proteins. (b) Stability of the
oxin (Fd), monitored at 420 nmat pH4.5 (green). (c) Stability of the 2Fe–2S cluster ofWT
H87Cmutation affects the visible spectrum and the stability of the Fe–S cluster of themu-
eNAF-1 2Fe–2S cluster is dependent on pH, at pH 8.0 NAF-1's cluster ismore stable than at
ter (orange and purple, respectively). The stability of NAF-1was compared with that of Fd
ent.
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which 650 were 2Fe–2S proteins (Fig. 3). Unexpectedly, the protein
was a homodimer, and contained a unique fold termed the “NEET
fold” [24]. The structure clearly indicated two distinct domains; a
beta-cap and a 2Fe–2S cluster binding domain (Fig. 3A). The cluster
binding domain is in general more hydrophilic and charged, whereas
the beta cap domain contained a hydrophobic core (Fig. 3B, C).
Sequence alignment and earlymutagenesis experiments [20] identi-
ﬁed the potential ligands of the mNT 2Fe–2S cluster assuming that it
was monomeric, an assumption that was proved wrong by the crystal
structures. The structures provided unambiguous details of the Fe–S
binding region, indicating that the outer Fe atom is coordinated by
one Cys and one His side chain. This unique coordination of the Fe is a
type of hybrid between the ferredoxin proteins that bind the outer Fe
with two Cys and the Rieske proteins that bind the outer Fe with two
His [27] (Fig. 4).
TheN-terminus of theNEET constructs, composed of amino acid side
chains that connect the transmembrane helix to the cytoplasmic C-ter-
minal cluster binding domains, is generally not resolved in the crystal
structures. In some cases, in which the N-termini were resolved, the
N-termini of the two protomers showed different conformations
resulting from different interactions with the N-termini of symmetryFig. 3. Structural comparison of the human NEET proteinsmitoNEET (PDB ID: 2QH7) and NAF-1
similar backbone fold and harbors two 2Fe–2S clusters in the same juxtaposition. (b) There a
differences in the distribution of aromatic side chains shown in yellow. (c) There are notable d
of the twoproteins. (B) Details of the 2Fe–2S cluster binding site ofmitoNEEThighlighting the co
binding regions. NAF-1 shares the same coordination as found in mitoNEET and also the similarelated molecules [28]. These results indicate that there is ﬂexibility
leading to multiple conformations of the N-termini in the soluble con-
structs that can be trapped in different orientations within a crystal.
For example, the structure presented in RCSB PDB ID: 2R13 [26] showed
completely different orientations and secondary structure of the N-
termini than those in RCSB PDB ID: 3EW0 [28]. Thus, the N-termini of
the soluble crystallized NEET constructs, which reﬂect the amino acids
linking the transmembrane helix to the ordered cluster binding do-
mains in the full length protein, are not well structured providing evi-
dence that the linker region is ﬂexible (Fig. 5). This may be important
for interactions with the OMM, with other membrane-bound proteins
and/or with soluble cytosolic proteins.
Crystals of the soluble region of the human paralog NAF-1 (Miner1)
were obtained under similar conditions to mNT [21]. The crystal struc-
ture was solved to a resolution of 2.1 Å (R-factor = 17%). As with
mNT, NAF-1 is a homodimer harboring two redox-active 2Fe–2S clus-
ters, one on each protomer (Fig. 3). As NAF-1was shown to be causative
in Wolfram Syndrome 2 [14], the NAF-1 structure showed for the ﬁrst
time an association of a redox-active Fe–S protein with this disease
(see more details below). As in mNT, each 2Fe–2S cluster in NAF-1 is
bound by the same rare 3Cys–1His motif within a 16 amino acid seg-
ment. However, it should be noted that there is a change in the beta(PDB ID: 3FNV). (A) (a) The overall structure of both proteins is homodimeric, has a very
re notable differences in the hydrophobicity between NAF-1 and mNT as shown by the
ifferences in the surface shape and charge distributions (red — negative, blue— positive)
ordinating ligands and a nearby interprotomer interaction. (C) Details of theNAF-1 cluster
r key interprotomer interactions with His58 of mitoNEET being Asn84 of NAF-1.
Fig. 4. Comparison of the 2Fe–2S cluster of ferredoxin (PDB ID: 1RFK), Reiske (PDB ID: 2NUM) and humanNEET proteins (mNT PDB ID: 2QH7 and NAF-1 PDB ID: 3FNV). (A–B) Structural
comparison of the 2Fe–2S coordination. Structures of NEET proteins (c, f) reveal the details of the Fe binding to the proteins. They indicate that the outer Fe (the right-most iron atom) is
bound by one Cys and oneHis. This unique coordination of the Fe being a type of hybrid between the ferredoxin proteins (a, d) that bind the outer Fe with two Cys and the Rieske proteins
(b, e) that bind the outer Fe with two His. (C) The absorption peaks of the 2Fe–2S clusters in the different proteins. UV–vis spectra were distinct (ferredoxin, black; mitoNEET, blue; Rieske,
green). The mitoNEET 2Fe–2S cluster absorbance peak is more similar to that of the Rieske 2Fe–2S cluster that is coordinated by 2Cys:2His.
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2Fe–2S clusters of NAF-1 [21]. Importantly, there are also signiﬁcant dif-
ferences in the surface charge and hydrophobicity that contribute to the
speciﬁcity in possible interactions by NAF-1with protein partners, vs. its
analogue mNT (Fig. 3A–C).
As the single His ligand is a hallmark of NEET proteins (Fig. 3B & C)
and replacement of the single His ligand with Cys (in mNT H87C mu-
tant) results in large changes to the properties of mNT ([20], and see
below), we determined the structure of the H87Cmutant under similar
conditions used to determine the native structure [28]. All structural
changes in the H87C mutant were found to be localized to the region
near the site of the mutation. The Cys87 was found to be in two confor-
mations as well as the Lys55 which forms hydrogen bonds with the na-
tive His87. No other changes were observed in the crystal structure
indicating that changes to the 2Fe–2S cluster properties resulted from
localized effects. More recently, we also determined the structure of
the equivalentmutation in NAF-1, H114C (29). In this case, a single con-
formation of Cys was determined. As with mNT, in the H114C NAF-1
mutant a change in the nearby Lys (Lys81) was identiﬁed. The high
structural similarity (almost identical) between the native NAF-1 and
H114C mutant shows that the biophysical, biochemical and biological
differences between these two variants are primarily due to the change
in the 2Fe–2S ligation of these proteins.2.3.2. Structures of other orthologs of NEET proteins
The NEET family of proteins is ancient being found in all domains of
life [30]. The human NEET ortholog from the plant Arabidopsis thaliana
was recently found to have the same NEET fold and cluster ligation
(Fig. 6A) as the human mNT/NAF-1 proteins, but differed in its surface
electrostatics and hydrophobic properties [31].
Bacteria were found to have NEET orthologs that are more similar to
Miner2, being a single polypeptide harboring two 2Fe–2S clusters
(Fig. 6B). The fact that the 3Cys:1His coordinated 2Fe–2S clusters are
conserved from bacteria to humans suggests an important ancient role
for these proteins in basic cell survival functions. Using bioinformatics
tools such as domain fusion and phylogenetic analysis, many of the bac-
terial NEET homologs were found fused to redox active proteins [30]; a
ﬁnding that supports an ancient role forNEET proteins in electron trans-
fer reactions. One of the non-fused prokaryotic versions, isolated from
Magnetospirillum magneticum AMB-1, an aquatic alpha bacterium that
utilizes iron reduction to derive energy, was presented as a bacterial
ortholog ofMiner2 [30]. The structure of this protein revealed an overall
fold that is quite similar to that ofmNT andNAF-1with two 2Fe–2S clus-
ters, each coordinated by the hallmark 3Cys:1His (Fig. 6B). The major
difference was that as opposed tomNT and NAF-1, theMiner2 ortholog,
is a monomer, not a homodimer (Figs. 3 & 6B), and its two 2Fe–2S c-
lusters are bound at two different parts of the sequence of the single
Fig. 5. The connecting soluble-membrane region of the NEET proteins shows high degree
of ﬂexibility. NEET proteins are composed of two stable structural domains that comprise
most of the soluble region of the proteins, the beta-cap and cluster-binding domains. The
N-terminal region includes a transmembrane helix and a segment that connects the solu-
ble domains to the helix. This connecting loop shows a high degree of ﬂexibility. The latter
is clearly evident when various structures of the mNT proteins are superimposed.
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share several common features: the presence of a cluster binding do-
main and a beta cap domain and the presence of two 2Fe–2S clusters
each bound by 3Cys and 1His in essentially the same relative juxtaposi-
tion with respect to each other with internal (pseudo) dyad symmetry.
2.4. Biophysical properties of the NEET 2Fe–2S clusters
The unique 3Cys:1His coordination of NEET proteins enabled the
comparison of their biophysical properties to that of ferredoxin and
Rieske proteins that have the outer Fe of their 2Fe–2S cluster coordinat-
ed with two Cys or two His, respectively (Fig. 4, above). The three gen-
eral techniques utilized for such comparison were EPR (Electron
Paramagnetic Resonance) which senses the environment of the un-
paired electrons in transition metal centers in proteins, resonanceFig. 6. Structure of NEET homologs from other organisms. (A) Structure of the NEET protein fro
(B) Structure of the Miner2 ortholog fromMagnetospirillum magneticum AMB-1 (PDB ID: 3TBN
position as found in the homodimeric NEET proteins.Raman spectroscopy which monitors vibrational transitions coupled
to an electronic transition of the oxidized 2Fe–2S cluster, and redox
(reduction/oxidation) potential measurements which is a measure of
the ease of transition from the oxidized to the reduced state (Fig. 7).
The results obtained from each of these biophysical methodologies are
described below.
To investigate the electronic structure of the NEET cluster in its re-
duced state, we used multi-frequency and multi-technique EPR spec-
troscopy [32]. The reduced cluster was found to have a rhombic g
tensor with an average g value of 1.947 that falls between those of
Rieske-type and ferredoxin-type [2Fe–2S]2+ clusters (Fig. 7A). From
simulation and least-squaresﬁtting of themultitude of data,we inferred
the absolute g tensor orientation with respect to the cluster. Important-
ly, in X-band (9 GHz microwave frequency) ENDOR (Electron Nuclear
DOuble Resonance) and ESEEM (Electron Spin Echo EnvelopeModula-
tion) spectra, a coupled nitrogen is visible, attributed to the Nε of the
histidine in the protonated state. The latter is absent in the H87C mNT
mutant, in which the cluster is coordinated by 4 Cys. We found that
the native cluster is in a valence-localized state,where the electron is lo-
calized to the outer iron bound by the His. The ﬁeld-sweep spectra
showed evidence of inter-cluster dipolar coupling, indicating that the
clusters interact with each other (Fig. 7A). Similar results were reported
for the rat homolog ofmNT [33]. These parameters can be considered as
reporters of the NEET proteins in general, and of how their cluster struc-
ture is altered upon a change in its environment. The coupling observed
between the clusters show that they communicate and could undergo
intra-dimer electron transfer. Furthermore, the coupling implies that
changes to one 2Fe–2S cluster can affect the properties of the other
2Fe–2S clusters.
Interestingly, the EPR results are comparable to previously published
data from 1978 on Fe–S proteins in mitochondria. Isolation of the OMM
yielded an X-band EPR spectrum showing the presence of two types of
2Fe–2S clusters [34,35]. The spectra they observed are essentially iden-
tical to that found for the homodimeric mNT; the two apparent types of
clusters due to spectral splitting caused by the interaction between the
clusters within the homodimer. Importantly, this shows that the pro-
teins harbor redox active 2Fe–2S cluster in vivo.
To study the oxidized state of the 2Fe–2S cluster, resonance Raman
spectra was used to characterize this naturally occurring 3Cys:1His
2Fe–2S protein and to assess local structural changes associated with
its cluster lability (Fig. 7B) [36]. Comparison of mNT to its ferredoxin-
like mNT H87C mutant, in which the cluster is coordinated by 4-Cys,m Arabidopsis (PDB ID: 3S2Q). It is homodimeric as are the human mitoNEET and NAF-1.
) [30]. In this case, a single polypeptide binds two 2Fe–2S clusters in a very similar juxta-
Fig. 7. Electron paramagnetic resonance, resonance Ramanand redox characterization ofmitoNEET. (A) Relative orientation of the two2Fe–2S clusters of homodimericmitoNEETbased on
the structure (PDB ID: 2QH7). EPR spectra of the fully reduced and partially reduced mitoNEET are shown below. Note that the splitting in the low ﬁeld region (near 335mT) is absent in
the partially reduced sample reﬂecting the absence of the intercluster interaction [32]. (B) Resonance Raman spectra of oxidized native (A–C) and H87C (D–F) humanmitoNEET as a func-
tion of pH; pHdecreases from top to bottom. Note the differences in the low frequency region (250–300 cm−1) between native andH87C showing that this region is sensitive to theHis87.
Also note that this region shows pH sensitivity in the native but not the H87C mutant mitoNEET [36]. (C, D) Redox range of mutant mitoNEET proteins. (C) Part of the structure near the
2Fe–2S clusters highlighting residues important for modulating the redox potential. (D) Measured redox potentials of mutants that both decrease and increase the redox potential by
N300 mV giving a total unprecedented range of approximately 700 mV. Typical cellular redox potentials are shown on the bar next to the plot. Mutant redox potentials span the entire
range [47].
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of mNT are inﬂuenced by the Fe–His87 moiety. Systematic pH-
dependent resonance Raman spectral changes were observed in this
spectral region for native mNT but not the H87C mutant. The approxi-
mately 250–300 cm−1 region of native mitoNEET is also sensitive to
phosphate buffer, which stabilizes the cluster from release [36] and
was shown to bind near His87 in the crystal structure [37]. Thus, condi-
tions that inﬂuence cluster release were shown to be concomitantly af-
fected by the resonance Raman spectrum in the region with Fe–His
contribution. These results support the hypothesis that the Fe–N(His87) interaction is modulated within the physiological pH range,
and this modulation may be critical to the function of mNT.
To determine the energy required to reduce the 2Fe–2S cluster we
used both protein ﬁlm voltammetry (PFV) and optical potentiometric
measurements to investigate the redox potential under different condi-
tions and in native andmutant proteins. Using eithermethod, the redox
potential of mitoNEET was near 0 mV at pH 7.0. Because addition of
higher concentrations of TZDs to buffered solutions results in insoluble
precipitate that interfered with optical methods, PFV was employed as
a mean to demonstrate the direct impact of TZD drug binding on the
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tential at pH 7was lowered bymore than100mV, shifting from approx-
imately 0 to−100 mV. This shift shows that the TZD prefers to bind to
the oxidized state [38]. In the H87Cmutant the redox potential was de-
creased nearly 300 mV due to replacing the His ligand with a Cys. This
moved the redox potential in the range more common to ferredoxin-
like proteins with 2Fe–2S clusters coordinated with 4-Cys (recently
reviewed for iron–sulfur proteins in Bak and Elliott [39]). Importantly,
the addition of TZDs had no effect on the redox potential in the H87C
mutant, showing that the drug binding isweaker in themutant and sug-
gesting that the drug interacts near His87 [38].
Redox potential measurements can also be used for titration of key
amino acid residues by measuring the variation in the redox potential
as a function of pH. Although these measurements provide a wealth of
information, the interpretation is model-dependent. As previous results
indicated the importance of His87 for stability and spectroscopic prop-
erties, we wanted to determine the pKa values for the key His87 ligand;
there are two pKa values, one associatedwith the oxidized state andone
associated with the reduced state of the 2Fe–2S cluster. Two different
methods were utilized — one was measurement of the redox potential
of protein in solution using optical potentiometric methods and the
other using protein bound to a surface using protein ﬁlm voltammetry.
The values and pH proﬁles of the two methods were in general agree-
ment [38,40,41]. The pH dependence of mNT displayed nearly classic
behavior in the decrease of Em versus pH for a single titrating site. How-
ever, for quantitative ﬁt to the data, a second term needed to be includ-
ed. One model included a second titrating site which provided an
improved ﬁt and could be applied to a comprehensive set ofmutants in-
vestigating the hydrogen bonding interactions near the 2Fe–2S clusters
[40]. An alternativemodel included an empirical term to account for de-
viations from an ideal slope; this term was to account for the net effect
of numerous small effects that occur over the pH range of the measure-
mentswithout speciﬁc assignments of pKa values. This lattermodelwas
applied to a set ofmutants designed to extend the range of redox poten-
tials through amino acids in the vicinity of the 2Fe–2S clusters to exact
mainly the pKa values for His87 [41]. Both models provided a similar
value for the pKa of His87 in the oxidized state of ~7. However, they
made quite different predictions in the pKa of His87 in the reduced
state. To distinguish between the models, we employed a more direct
method using optical titration of the 2Fe–2S cluster absorption bands.
The basic idea is that as His87 protonates, the interaction between
His87 and the 2Fe–2S cluster is perturbed resulting in a change in the
energy of electronic transition (ligand to metal charge transfer bands)
and, hence, a change in the optical spectrum. This allowed us to directly
titrate the ligands to the 2Fe–2S cluster and the results showed unam-
biguously that the pKa of His87 in mNT is 6.8 (oxidized) and 12.4
(reduced) favoring the latter model as a better description of the
His87 interactions. Although this model provides better values for the
interaction, it introduces an empirical parameter that cannot be directly
related to amino acid titrations. Thus, neithermodel on its own provides
a complete satisfactory description of the observed behaviorwarranting
further more sophisticated reﬁnements to the modeling. Nevertheless,
the large change in the pKa values (~5.6 units) of His87 reﬂects a very
strong interaction between it and the 2Fe–2S cluster consistent with
the EPR and resonance Raman studies discussed above.
Next we tested the ability to vary the redox potential of the clusters.
The ability to “tune” an 2Fe–2S cluster redox potential over awide range
had been limited in many other 2Fe–2S proteins by instability of the
clusters uponmutation of amino acids at or near the clusters [41]. Nev-
ertheless, we were able to mutate key residues near the 2Fe–2S cluster
and obtain, for most mutations, proteins with intact and redox-active
clusters. From the set of mutations stable enough to obtain good redox
measurements, we were able to vary the redox potential over an un-
precedented range of ~700 mV and with the ability to both increase
and/or decrease the redox potential to span the entire range of poten-
tials reported in cellular environments (Fig. 7C) [41]. Some additionalmutations were also recently reported to fall within this range [41].
Overall, mNT is quite tolerant to amino acid substitution at and near
the 2Fe–2S cluster binding sites, making it a great model system for
studying the “tuning” of redox potentials. The redox potentials of
NAF-1 were also measured and found to be essentially the same as
that of mNT [21,29]. The redox potential of NAF-1 similarly displayed
a strong dependence on pH above pH7 showing that electron reduction
is also coupled to protonation. In both mNT and NAF-1, we recently
discovered that long-range allostery can also tune the 2Fe–2S potential.
2.4.1. Allostery in mNT affects its 2Fe–2S cluster properties
Recently, the importance of allostery inmNTwas explored both the-
oretically and experimentally (Fig. 8) [42]. It was found that a loop (L2)
20 Å away from the 2Fe–2S cluster exerts allosteric control over the
cluster's redox properties. Substitution of amino acid side chains of L2
resulted in shifts of up to 100 mV in the redox potential of the 2Fe–2S
clusters and a more than 15-fold change in the rate of 2Fe–2S cluster
transfer to an apo-acceptor protein (see below). These surprising effects
occur in the absence of any crystallographic structural changes. An ex-
amination of the native basin dynamics of the protein using all-atom
simulations shows that twisting in L2 controls scissoring of the cluster
binding domain that results in perturbations to one of the cluster-
coordinating histidines. These allosteric effects are in agreement with
previous folding simulations that predicted L2 could communicate
with residues surrounding the metal center [43]. They resemble similar
allosteric cross-talk reported for the ferredoxin 4-Cys coordinated pro-
tein [44]. Our ﬁndings suggest that long-range dynamical changes in
the protein backbone can have a signiﬁcant effect on the functional
properties of NEET proteins and suggest possible allosteric regulation
of the cluster properties and function.
Taken together, the mNT/NAF-1 biophysical characterization by nu-
merous methodologies supports two possible cellular functions for
NEET proteins (Fig. 9): i. cluster transfer function (Fig. 9, blue arrows)
and/or ii. electron transfer function (Fig. 9, purple arrows).
3. Cellular and whole organism function of NEET proteins
In recent years, building upon the detailed biophysical character-
ization of NEET proteins, some of the research of NEET proteins
shifted towards understanding their biological/cellular/whole or-
ganism function(s). In parallel, the involvement of mNT and NAF-1
in different pathologies, as well as in health (longevity) has emerged
as highly important.
3.1. NEET proteins as cluster donor proteins
One of the possible cellular functions of NEET proteins initially sug-
gested for mNT based on the earlier biophysical results was cluster
transfer (Fig. 9). Because the His87 of mNT and the His114 of NAF-1
can undergo changes in protonation near neutral pH, protonation was
suggested to be a “gate” or “trigger” for cluster release/transfer [24]. A
similar coordination (with a histidine present) was proposed for
human IscU (Iron Sulfur Cluster assembly enzymeU) based on the crys-
tal structure of a bacterial homolog [45]. This similarity in the coordina-
tion of the 2Fe–2S cluster, in addition to the fact that the 2Fe–2S cluster
appears to be labile by design, strengthens the hypothesis that NEET
proteins may be able to perform a similar biological function as cluster
donor proteins that transfer their 2Fe–2S cluster to an apo-acceptor pro-
tein. For this transfer to occur, and to have an experimental system to
test it, an appropriate apo-acceptor had to be found. To date the physi-
ological apo-acceptor protein(s) of NEET proteins was not identiﬁed,
and since the apo-acceptor gold standard of such studies [46] is apo-
ferredoxin (apo-Fd) this protein was tested as a possible cluster accep-
tor protein. The fact that the ferredoxin (Fd) cluster is tightly coordinated
by the 4-Cys coordination (see Fig. 4, above), secures a tighter binding of
the cluster to Fd following the cluster transfer and facilitates a uni-
Fig. 8. Effect of allostery inmitoNEET function. (A) Replacement of distal residues in a loop at the top (L2) result in both positive and negative shifts in the 2Fe–2S cluster redox potential at
pH 7 (EM,7). (a) Mutated residues in L2 are colored in blue on the structure of mitoNEET. (b) Coordination of the [2Fe–2S] remains unaltered in the mutant mitoNEET crystal structures.
(c) EM,7 values forWTmitoNEET and L2mutants span a range of ~60mV (SHE values). (B) Twisting in L2 controls swinging of His87. (a) Ten frames from the collectivemotions of the Cα
atoms for the ﬁrst eigenvector are superimposed on the structure. The initial starting point is colored white, with each subsequent frame moving from white to red for protomer A and
white to blue for protomer B. From the topview, theprotein exhibits a torsionalmotionwith the loops twisting together at the top of the beta-capdomain in the foreground, and the cluster
binding domainmoving in the opposite direction in the background. (b) The side view of the protein shows that the twisting of the β-cap domain results in scissoring of α1 and L1′with
α1′ and L1 in the cluster binding domain,with the [2Fe–2S] cluster acting as a hinge point. (c) The backbone of the cluster-coordinating pocket and the coordinating cysteines shows little
movement; however, the coordinating histidine swings open in response to twisting in L2. These computational results provide a framework to interpret the experimental ﬁnding that
properties of the cluster can be altered by distant mutations without changes to the crystal structure [42].
Fig. 9. Proposed functional roles of theNEET proteins.MitoNEET is shown linked (magenta
and green) to the OMM (gray) (not to scale). On the basis of mitoNEET biophysical prop-
erties, two possible functions are suggested: cluster transfer (blue arrows) and electron
transfer (purple arrows). The left side shows possible cluster transfer reactions. The
right side (purple) shows possible reduction reactions of the 2Fe–2S clusters. Biophysical
and biochemical results show that His-87 is a key ligand for cluster transfer (release) and
tuning the redox potential [24].
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and acceptor proteins can be distinguished spectroscopically — the Vis
spectra of NEET proteins has a peak absorption at 458 nm which is dis-
tinct from that of Fd which has a peak absorption at 423 nm. The latter
results from the difference in the coordination of the 2Fe–2S clusters
and is reﬂected in the Vis spectra as ligand-to-charge transfer bands. An-
other prerequisite for a cluster transfer process to occur is that the NEET
protein and Fd should have the ability to bind one another. Fig. 10 shows
that NAF-1 and Fd association is possible (Fig. 10A, B) and that a cross-
linker (Fig. 10C) can even enforce a permanent association (Fig. 10D,
E). Fig. 11 shows that cluster transfer can occurwhenNAF-1 is incubated
with pre-reduced apo-Fd in which the sulfur atoms of the cysteines in
the cluster binding site are reduced (free thiol-SH) [29,47]. The reduction
of the cysteines in the cluster binding site of the acceptor protein was
successfully performed both by chemical reducing agents such as β-
mercaptoethanol or sodium dithionite dithiothreitol (DTT), and by natu-
ral, biological reducing agents found in living cells such as glutathione or
thioredoxin [23,47]. Cluster transfer studies indicated that in order for
the transfer to occur, the cluster of the donor protein has to be in its ox-
idized [2Fe–2S]2+ state.
In the NEET cluster transfer assays (Fig. 11), incubation of holo-NEET
and pre-reduced apo-Fd in vitro indicated, both by native gel and optical
spectroscopy, that NEET proteins transferred their iron–sulfur cluster to
apo-Fd forming holo-Fd with a concomitant decrease in holo-NAF-1.
The twomethods provided complementary conﬁrmation of the transfer.
The difference in visible spectra of the NEET donor and Fd acceptor pro-
vided us with a spectroscopic ﬁngerprint of the process as transfer takes
place (Fig. 11C). The difference in their migration rates in native-gels
provided a more visual picture of the transfer process (Fig. 11B). The
Fig. 10. The NEET protein NAF-1 and apo-Fd can interact as cluster donor and cluster acceptor proteins, respectively. (A) A protein–protein complexmodel of NAF-1 (blue) and Fd (green)
suggested after a global docking run by the ClusPro docking server [117]. The obtained lowest energy models place the clusters side-by-side with few different orientations. (B) The cal-
culated surface chargemaps of NAF-1 (a) and ferredoxin (b) show the blue-cationic and red-anionic residues demonstrating the structural complementarity. (a) and (b) panels show the
surface of each protein at the area of binding and (c) and (d) panels show the interacting proteins. (C) BMB crosslinker's molecular scheme (a) and reaction of maleimide-activated com-
pounds to sulfhydryls (b). (D) Surface of NAF-1 (blue) and Fd (green) at the area of binding. The cysteine residues from the cluster binding domains are colored red. (E) The mixture of
NAF-1 and (apo) Fd together with the crosslinkers BMB results in a new pattern of bands (right-hand lane) on a native gel compared to the lane that consists the proteins without the
cross-linker (left-hand lane).
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matically demonstrated in Fig. 11A.
By monitoring the spectra as a function of time, we were able to
show thatmNT could transfer its 2Fe–2S cluster to a canonical ferredox-
in acceptor (Fd)with an almost 100% transfer efﬁciency and, surprising-
ly, at a rate comparable to cluster transfer rates reported for an iron–
sulfur assembly protein (Fig. 12). These results underlined the hypoth-
esis that at least one function of NEET proteins in cells is 2Fe–2S cluster
transfer (Fig. 12). To investigate the importance of His87 in the cluster
transfer function, we measured the extent and rate of transfer from
the H87C to Fd. The mutant showed essentially no cluster transfer
over the time of the experiment (half time N30× that of native
mitoNEET). Thus, His87 is particularly important for the cluster transfer
process.
The ability to measure cluster transfer provided a second functional
assay, on top of cluster stability assays [47], for measuring small mole-
cule binding and for investigations of protein–protein interactions. In
addition, determination of the rates of cluster transfer provided a mea-
sure of the protein dynamics uponmutation as changes in regions calcu-
lated to be very dynamic parts of the structure resulted in changes of up
to 15-fold in the rate of transfer of the 2Fe–2S clusters to Fd [42].
The ability of NAF-1 to function as a cluster donor was also tested
and found to be similar to that of mNT [23]. Although the ability ofMiner2 to transfer its clusters has not been established, the similarities
between this protein and mNT or NAF-1 suggest that a similar cluster
transfer function could also be assigned to this protein. Moreover,
since the ability to transfer the 2Fe–2S cluster in its entirety andwithout
loss has only been observed in proteins involved in cluster assembly or
transfer, our ﬁndings that mNT and NAF-1 satisfy those conditions sug-
gest their potential involvement in cluster assembly/transfer processes.
3.2. NEET proteins' cluster/iron transfer to mitochondria in cells
TheNEET proteins unique cellular localization (on the cytosol-facing
membranes of the ER andmitochondria), enable in principle, their func-
tion as cluster/iron transfer protein into- and out of these organelles. In
order to test whether the transfer of cluster/iron into the mitochondria
is at all possible, and to characterize the ability of NEET proteins to trans-
fer their cluster/iron in situ, in cells, Rhodamine B-[(1,10-Phenanthrolin-
5-yl)-Aminocarbonyl]benzyl ester (RPA), a ﬂuorescent metal sensor
that accumulates within mitochondria of living cells, was used. RPA is
the conjugate of the cationic ﬂuorophore rhodamine and the iron chela-
tor phenanthroline. When iron binds to the chelator phenanthroline,
the ﬂuorescence of RPA is quenched (Fig. 13A). RPA ﬂuorescence
could therefore be used as a reporter of iron levels withinmitochondria
[48–50]. To test for the ability of NEET proteins to transfer their Fe/Fe–S
Fig. 11. Optical spectroscopy and Native-PAGE are among the analytical methods to follow cluster transfer fromNEET protein (donor) to apo-Fd (acceptor) to obtain holo-Fd. (A) A sche-
matic representation of cluster transfer from NAF-1 to apo-Fd. (B) NAF-1 was incubated at 37 °C with a β-mercaptoethanol-reduced apo-Fd for 30 min and the products were run on a
native gel. The Native-PAGE following the cluster transfer from holo-NAF-1 to apo-Fd (lane 2), holo-NAF-1 mutant H114C to apo-Fd (lane 3) and holo-Fd to apo-NAF-1 (lane 4). Holo-
NAF-1 and holo-Fd are shown for reference (lane 1). The red colored bands are indicative of the [2Fe–2S] cluster in the two proteins; the upper red band represents NAF-1 (labeled
NAF-1 on the right side of the gel) and the lower red band represents holo-Fd (labeled Fd). A Coomassie stain of the native gel directly below illustrates that the protein levels in all of
the experimental samples are the same. (C) The UV–vis absorption spectroscopy of the incubation samples before and after a 60 minute cluster transfer incubation, as above. The
peaks of holo-Fd and of NAF-1 absorptions are marked (423 and 458 nm, respectively). (D) Replacement of a single-coordinating His114 in NAF-1 with Cys (H114C) shows no transfer
to apo-Fd [29].
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mild surfactant digitonin to allow for the penetration of NEET proteins
(Fig. 13B). The effect of NEET addition on RPA ﬂuorescence was then
measured with an Epi-ﬂuorescent microscope. As a ﬁnal assurance
that all ﬂuorescence is quenched, iron is added to the cells in the form
of FeHQ (FeCl3/8-hydroxyquinoline complex). Fig. 13A–B describes
the experimental tools and work ﬂow, and Fig. 13C–D shows a repre-
sentative example of typical results using H9c2 rat cardiomyoblast
cells. In this example the addition of NAF-1 led to the quenching of theRPA ﬂuorescence in a concentration-dependent manner [23]. Similar re-
sults were obtainedwhenmNTwas added to HEK-293 cells [47]. Howev-
er, the addition of the mutated proteins with four cysteines in the cluster
binding site, H87CmNTmutant, or H114CNAF-1mutant, did not result in
quenching showing that theywerenot effective Fe/Fe–Sdonors to themi-
tochondria. These results show the importance of the unique 3Cys–1His
coordination for Fe/Fe–S donation in cells [23,47] and are in agreement
with the in vitro cluster transfer data described above. Additional cell
biology tools used to study NEET function in cells included TMRE
Fig. 12. Rates and quantiﬁcation of cluster transfer from mNT to apo-Fd. The presence of the [2Fe–2S] cluster in mNT can be observed by UV–vis spectroscopy with a signature peak at
458 nm and in Fd at 423 nm. Frames A through D show the cluster transfer reaction progress (in the speciﬁed times). The observed spectra for the combined species are shown as a
black line at the top of each frame while the deconvoluted spectra of holo-mNT (red) and holo-Fd (orange) are shown below. (D) Upon approaching completion, the visible spectrum
resembles that of Fd, as all apo-Fd has been converted to the holo form and mNT has been converted to the visible-lacking apo form. The upper right corner in each spectrum indicates
the percent completion for the cluster transfer reaction. (E) Transfer of mNT's (mtN) [2Fe–2S] cluster to apo-Fd (aFd) is also observed by Native-PAGE. Upon incubation with apo-Fd,
mNT shows diminished color, indicating cluster loss over time as the [2Fe–2S] cluster is transferred to apo-Fd evident as a smallermolecularweight red-colored band indicating formation
of holo-Fd. (F) In addition, 55Fe-labeled mNT (mtN) was shown to transfer its cluster to apo-Fd (aFd) by Native-PAGE and radioactively detected [47].
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sensing changes in the levels of mitochondrial membrane potential
(MMP), or reactive oxygen species (ROS), respectively upon disruption
of NEET proteins' levels (see below) [51]. It should be noted that transfer
of iron/cluster from NEET proteins to mitochondria upon addition of pu-
riﬁed NEET proteins to permeabilized cells was used to demonstrate the
ability of NEET proteins to donate their clusters in cells. As described
below, a multitude of approaches was used in recent years in an attempt
to decipher the biological function of NEET proteins.
3.3. The involvement of NEET proteins in key cellular process
3.3.1. NAF-1 is involved in autophagy regulation via interactions with Bcl-2
Different environmental conditions, such as hypoxia, nutrient star-
vation, or viral infection, as well as different developmental programs,
can trigger several alternative pathways in cells including apoptosis, a
form of programmed cell death, or autophagy, a pathway for cell surviv-
al that results in a selective degradation of cellular components and the
recycling to basic building blocks and energy equivalents [52,53]. A
basal level of autophagy is vital for homeostasis in the cell as nutrient
supply ﬂuctuates in the natural environment. Increased autophagy
could occur for example during stress, caused by extracellular factors
such as severe deﬁciency in nutrients, hypoxia, or accumulation of
ROS, that leads to the accumulation of defective proteins and organelles.
Due to their life-or-death decision role, apoptosis and autophagy are of
course under strict cellular regulation. The controlmechanisms on these
processes involve large protein complexes that perceive signals from
the cell and/or the environment and respond accordingly [54–57]. The
NEET protein, NAF-1, along with Bcl-2 was shown to be part of one
such complex, and NAF-1 was found to be necessary for the function
of Bcl-2 in the control of autophagy at the ER [55]. Bcl-2's role in this
control is to anchor the Beclin-1 complex, essential for the formation
of the autophagosome, to the ER, thereby inhibiting autophagy. Bcl-2
does not bind the Beclin-1 complex when a member of the BH3-only
protein family binds to it (Fig. 14B). It was suggested that NAF-1 along
with the IP3 receptor, a channel for calcium ions in the ER membrane,
forms the foundation for Bcl-2 anchoring to the ER and to the Beclin-1
complex (Fig. 14A).To obtain molecular details on the interaction between NAF-1 and
Bcl-2, several functional assays were combined with binding assays
and a novel use of a computational technique called Direct Coupling
Analysis (DCA). The advantage of including functional assays is that
they are the ultimate indication that indeed binding has a functional
consequence. The ﬁrst use of such assays for deciphering the protein–
protein interactions involving a NEET protein was reported in [58] in
which we showed binding of Bcl-2 or Bcl-2 peptide(s) to NAF-1 and
studied the effect of this binding on NAF-1's 2Fe–2S cluster stability
and transfer [58].
The functional analysis of NAF-1 binding to Bcl-2 was com-
plemented with two other experimental techniques to obtain a de-
tailed map of these molecular interactions. One method was peptide
array analysis which identiﬁes peptide fragments from Bcl-2 to which
NAF-1 binds. The secondmethod used deuterium exchange mass spec-
trometry (DXMS) to identify parts of NAF-1 that exchange deuterium
more slowly when incubated in D2O upon binding of Bcl-2 and vice
versa. Combined, these techniques indicated that NAF-1 binds to
small segments of the BH3 and BH4 regions of Bcl-2 and to its disor-
dered loop.
The different sets of experimental results were then combined with
a new use of DCA which searches for co-evolved amino acids that are
expected at protein–protein interfaces. Because each technique on its
own has limitations and potential systematic errors, the combination
of the different platforms provided an unprecedented level of detail
for the interaction interface between NAF-1 and Bcl-2 that was not
possible by any subset of techniques on their own. The combined ap-
proaches yielded the molecular Bcl-2-NAF-1 interaction map presented
in (Fig. 14C–E) [58].
3.3.2. NEET proteins are involved in cellular and whole organism iron/ROS
homeostasis
The involvement of the NEET proteins in cluster/iron transfer to mi-
tochondria (Fig. 13) [23,47] hinted at a possible involvement of NEET
proteins in cellular iron homeostasis. To explore this possibility at the
whole organism level, studies were performed in the model plant
A. thaliana, in which genetic manipulations are easily established and
maintained, and phenotypic measurements are possible. A. thaliana
Fig. 13.Determination ofmitochondrial iron levels upon addition of NEET proteins to permeabilized cells. The experimental system: (A) The RPA probe: (a) the chemical structure of RPA—
the cationic ﬂuorophore, rhodamine is conjugated to the iron chelator phenanthroline via aminocarbonyl benzylester. The red ﬁlled mitochondria indicate a highly ﬂuorescent state.
(b) The formation of RPA/Fe2+ complexwith a stoichiometry 3:1 ratio. (c) Quenching of RPA upon bindingwith iron. (B) The cellular in situ system to analyze NAF-1 effects onmitochon-
drial iron levels: (a) a representative mitochondria in a cultured cell, (b) was stained with RPA (c) and the cultured cell was permeabilized using mild surfactant digitonin (d) intake of
NAF-1 proteins by simple incubation with cultured cells. (e) The ﬂuorescent change of RPA wasmonitored bymicroscopy over time. (f) The total quenching of RPA obtained using highly
membrane permeant FeHQ. Transfer of labile iron from NAF-1 to mitochondria. (C) Pseudo-colored images of permeabilized H9c2 cells labeled with red RPA to trace iron in the mitochon-
drial matrix. Change in RPA ﬂuorescencewasmeasured every 2 min. NAF-1 (WT or H114Cmutated) was added to concentrations of 0, 5, 10, or 20 μM after 4 min. The pseudocolor of the
cells indicates the relative levels of mitochondrial RPA ﬂuorescence (orange: high; blue: low). The highly membrane permeant FHQ was added after 22 min in order to attain maximum
quenching. (D) Plot of RPA ﬂuorescence (arbitrary units, a.u.) obtained by analyzing individual cell ﬂuorescence with the ImageJ program. The RPA ﬂuorescence is the average of four in-
dependent runs [23].
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NEET gene, At5g51720 (At-NEET) [31]. At-NEET was found to localize
to the chloroplast and to the mitochondria [31,59]. Phenotypic charac-
terization of At-NEET knockdown plants revealed a key role for this pro-
tein in plant development, senescence, reactive oxygen homeostasis,
and Fe metabolism (Fig. 15). A role in Fe metabolism was further sup-
ported by biochemical and cell biology studies of At-NEET in plant and
mammalian cells, as well as bymutational analysis of its cluster binding
domain. Our ﬁndings support the hypothesis that NEET proteins have
an ancient role in cells associated with Fe metabolism [31]. The results
obtained in the plant system were essentially the same as thoseobtained in mammalian cells and mice in which the levels of the NEET
proteins were decreased by either shRNA or gene knock out (KO) stud-
ies [51].
3.3.3. Interactions of mNT with proteins involved in cellular redox control
3.3.3.1. Thioredoxin/thioredoxin reductase. Recently, mNT was reported
to interact with the E. coli thioredoxin/thioredoxin reductase system,
demonstrating that these biological thiols can reduce the cluster of
NEET proteins both in vitro and in the E. coli cellular environment [60].
It was reasoned that if mNT is reduced in E. coli cells which have a
Fig. 14. Involvement of NAF-1 in autophagy. (A–B) Schematicmodel of the Beclin1/Bcl-2/NAF-1 complex and autophagy regulation at the ER. A simpliﬁed vision of the complex is shown
before (A) and after autophagy induction (B). NAF-1 was found to be necessary for the activity of Bcl-2 in the control of autophagy at the ER. Bcl-2's role in this control is to anchor the
Beclin-1 complex, essential for the formation of the autophagosome, to the ER thereby inhibiting autophagy. Bcl-2 does not bind the Beclin-1 complexwhen it is bound to anothermember
of the BH3-only protein sub-group. Itwas suggested thatNAF-1 alongwith the IP3 receptor, a channel for calcium ions in the ERmembrane, forms the foundation for Bcl-2 anchoring of the
Beclin-1 complex to the ER (adopted fromMaiuri et al. [57]). (C–D)NAF-1–Bcl-2molecular interactions: Predicted interacting surface of NAF-1 and Bcl-2 using an experimental/theoretical
integrated approach. (C) A putative interacting surface determined from DCA constraints (green links). The DXMS results showing all protected residues are highlighted in pink and dark
blue. Dark blue is the overlap betweenDXMS and the top 30 couples determined usingDCA. (D)NAF-1 and Bcl-2 are peeled apart and rotated by90° as indicated. (E) Bcl-2with interacting
peptides from the array is shown in orange, and DCA residues are in cyan. Dark blue is the overlap between the peptide array and DCA. The combination of techniques provides a more
detailed molecular model than is obtainable from any one technique on its own [58].
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the lower redox potential of eukaryotic cells (typically−325 mV).3.3.3.2. Glutamate dehydrogenase. A recent report showed a potential in-
teraction between apo-mNT and glutamate dehydrogenase (GDH1)
based on protein pull-down experiments using mNT as a bait [61].
mNT was found to form a covalent complex with GDH1 through disul-
ﬁde bond formation. This bond required however the loss of the 2Fe–
2S cluster from mNT. Upon complex formation, reduction of NAD+ by
GDH1 was accelerated by ~2-fold. The accelerated activity was lost
upon reduction of the disulﬁde bond. The authors suggest that mNT
(apo-mNT) acts as an allosteric modulator of GDH1, which is a mito-
chondrial enzyme with an important role in insulin secretion.3.4. mNT is involved in inﬂammatory and metabolic diseases
Following the discovery of mNT by Colca et al. [17], describing the
speciﬁc cross linking of mNT to thiazolidinedione (TZD), a type 2 diabe-
tes drug, several other publications reported the pharmacokinetics of
TZDs in relation to mNT [62–71]. TZDs are effective insulin-sensitizing
drugs for the treatment of metabolic and inﬂammatory diseases, but
their use is limited due to their side effects that are mediated by the ec-
topic activation of the peroxisome proliferator-activated receptor γ
(PPARγ). Several TZD-based anti-diabetic drugs have been removed
from the market due to these associated side effects. The connection
of mNT to TZDs suggests that these drugs could act through modiﬁca-
tion of mitochondrial metabolism, preventing metabolic inﬂammation
and allowing the up-regulation of mitochondrial biogenesis [72]. Mito-
chondrial activity and the etiology of obesity, insulin resistance and the
Fig. 15. Late bolting and early senescence phenotypes of Arabidopsis plants with suppressed expression of At-NEET. (A) Inﬂorescence height in thewild type (WT), knockdown plants, and
RNAi lines for At-NEET. A representative photograph of 38-d-oldwild type and two independent knockdowns for At-NEET is shown alongwith anRT-PCR gel for the expression of NEET in
the plants photographed. (B) Leaf number at the time inﬂorescence height reached 1 cm inwild-type knockdownplants and RNAi lines for NEET. (C) Photographof 58-d-oldwild type and
two independent NEET knockdowns grown under controlled growth conditions. (D) Chlorophyll content inwild-type knockdown plants and RNAi lines for NEET. Plants (58-d-old)were
grown under controlled conditions in a mixed plot setting [31].
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study showing that overexpression of mNT in adipocytes enhances
lipid uptake and storage resulting in anexpansion of themass of adipose
tissue [73]. Interestingly, overexpression of mNT in adipocytes of ob/ob
diabetes model mice increased the uptake and storage of lipids in adi-
pose tissue without a loss of insulin sensitivity [73]. This increased adi-
pose lipid accumulation was accompanied by a reduction in ectopic
lipid accumulation, which is associated with reduced insulin sensitivity.
Increased adipocyte production of the lipid uptake-promoting hormone
adiponectin was also observed. Mitochondrial iron levels were reduced
in these mNT overexpressing cells, leading to a decrease in activity of
the iron-dependent electron transport chain (ETC), lowering the rate
of β-oxidation. With reduced mitochondrial respiration, lower levels
of damaging ROS are produced. In addition to reducing iron transport
into thematrix,mNToverexpression loweredmitochondrialmembrane
potential and oxidative damage, and led to higher production of
adiponectin. The level of mNT expression was therefore found to mark-
edly affect the dynamics of cellular and whole body lipid homeostasis
[73].
Another recent study demonstrated the relationship between mNT
and the inﬂammatory mediator TNF-α in liver cells [74]. Exposure of
primary mouse hepatocytes to fructose and ethanol induced the
overexpression of mNT, which primed the cells for TNF-α induced
cytotoxicty. TNF-α induced the translocation of a Stat3–Grim-19 com-
plex to themitochondria,which boundmNT andpromoted the rapid re-
lease of its 2Fe–2S cluster, causing iron accumulation that led to
increased ROS resulting in mitochondrial injury and cell death. Further
understanding of the relation of mNT to metabolism and inﬂammation,
as well as the identiﬁcation of additional drugs that bind NEET proteins
could drive the development of future therapeutic strategies to treat
metabolic and inﬂammatory diseases [75].3.5. Interaction of the anti-type 2 diabetic drug pioglitazone and other small
molecules with NEET proteins
DecreasingmNT protein levels in mice reduces mitochondrial respi-
ration capacity. In heart cells ofmNT knockoutmice a decrease of 30% in
oxygen consumption was observed in addition to a similar decrease in
maximal uncoupler-stimulated respiration rate [18]. Damage to themi-
tochondria is often associated with resistance to insulin and the devel-
opment of type 2 diabetes [76]. In recent years it was suggested that
the pathogenesis of certain diseases lowers mitochondrial oxidation in
insulin-resistant tissues. Drugs targeting insulin resistance, such as the
TDZ pioglitazone, increase the oxidation capacity of cells [77,78] and
suppress the activity of complex I in the mitochondrial respiration sys-
tem [79].
As described above,mNTwas initially identiﬁed as a cellular TZD (pi-
oglitazone)-binding protein [17]. Upon mNT's isolation and crystalliza-
tion, functional measurements showed that addition of pioglitazone
stabilized the 2Fe–2S cluster of mNT [24]. Additionally, preferential
binding of pioglitazone to the reduced state of mitoNEETwasmeasured
using protein ﬁlm voltammetry [38]. Subsequently, a new cellular assay
was developed which showed that pioglitazone inhibits iron/Fe–S
transfer from mNT to the mitochondria [47]. In addition, high concen-
trations of pioglitazone were found to inhibit the interaction between
the thioredoxin/thioredoxin reductase complex and mNT [60].
Binding of other small molecules tomNTwas also investigated using
amolecular blind dockingmethod [66]. The results suggested a docking
site for pioglitazone and identiﬁed potential novel target molecules for
binding to mNT such as magnolol and enterobactin [66] (for review
see Geldenhuys et al. [80]). Resveratrol-3-sulfate was shown recently
to bind mNT [67]. The ﬁrst structure-based drug-designed mNT-ligand
was NL-1 [65,68] in which removal of the “tail” of pioglitazone
Fig. 16. Eliminating the function of NAF-1 leads to multiple symptoms in both human and
mice models. The CISD2 gene, shown at the top, codes for the OMM/ER protein NAF-1
(left-hand side). Wolfram Syndrome 2 (WFS2) is attributed to a single base pair conver-
sion in the CISD2 gene that results in a splicing error that completely eliminates exon 2,
causes a frame shift and introduces a premature stop codon in exon 3 (right-hand side)
[14]. For these reasons, 75% of the protein sequence is not translated, and no NAF-1 is
properly assembled in the OMM and ER (lower part of the right-hand side). The absence
of this protein causes a wide range of symptoms in WFS2 patients, including diabetes
mellitus and optical atrophy. In an independent study, CISD2 knockout mice have similar
symptoms (created based on Conlan et al. [21]).
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ﬁnity. Additionally, NL-1 mildly uncoupled the mitochondrial gradient
and was able to protect neuronal cells (N2A) against the electron trans-
port complex I toxin rotenone [68,81].
A biological molecule that affects the properties of the 2Fe–2S cluster
of mNT was ﬁrst reported by Zhou and coworkers [82]. They found that
mNT's cluster stabilitywas decreased by the binding of the cellular redox
regulator nicotinamide adenine dinucleotide phosphate (NADPH). They
determined by NMR and mutagenesis that residues K55 and H58 were
critical to this interaction. In addition to destabilizing the cluster, our
group found that NADPH inhibits the transfer of the 2Fe–2S cluster to
apo-acceptor proteins [69]. We determined a Ki of 0.2 mM for NADPH,
which is in the physiological range for the concentration of this com-
pound. These results suggest that NADPH is a cellular regulator of mNT
2Fe–2S cluster transfer to apo-acceptor proteins. Additionally, we
found through mutagenesis that residue D84 in the CDGSH domain
was necessary for the effect of NADPH binding on mNT cluster transfer
function. This residue is highly conserved in orthologs across all king-
doms of life, suggesting that the interaction between mNT and NADPH
might be of universal importance.
Pioglitazone and resveratrol, a small natural molecule that increases
life span [68], were also recently shown to bind to NAF-1 [23]. These
studies provided an explanation to the ﬁnding that pioglitazone could
still bind to the mitochondria of mNT knock-out cells, presumably
through binding to NAF-1 [71]. Incubation of NEET proteins with pio-
glitazone or resveratrol led to an increase in the stability of the 2Fe–2S
cluster and inhibited the transfer of Fe/Fe–S from the protein to themi-
tochondria in situ [23,47]. Screening of the electrostatic environment by
the addition of MgCl2 resulted in a slight acceleration of cluster transfer
from NAF-1 to the acceptor protein apo-Fd, and altering the hydropho-
bicity of the reaction conditions by the addition of glycerol dramatically
inhibited the transfer. These results suggested an important role for hy-
drophobic residues in the interactions and docking of pioglitazone or
resveratrol to NAF-1. Interestingly, the H114C mutant of NAF-1 was
not affected by any of the compounds indicated above and their pres-
ence did not enable H114C to transfer its cluster to the acceptor protein
[29,47].
3.6. mNT involvement in Cystic Fibrosis (CF)
Mutations in the CFTR gene (CFTR chloride channel) are known to
cause the autosomic recessive disease Cystic Fibrosis (CF). mNTwas dis-
covered to be a CFTR-dependent gene sincemNTmRNAwas found to be
down-regulated in cystic ﬁbrosis cells and its level restored by ectopi-
cally expressingwt-CFTR in CF cells [83]. In addition, inhibition of CFTR's
chloride transport activity resulted in down-regulation of mNT mRNA
while CFTR stimulation upregulated mNT expression. CF has been
shown to be associatedwithmitochondrial failure. The reduced expres-
sion ofmNT in CF cellsmay induce a failure in the electron transport and
oxidative phosphorylation of mitochondria thus contributing to the CF
disease phenotype [83].
3.7. NEET protein involvement in early neural development and
neurodegenerative diseases
Neurodegenerative diseases are often comprised ofmultiple disorders
that lead toneuronal cell death. A screen to identifymolecularmarkers for
early neuronal development found two previously unknown transcripts,
one of which (Noxp70 transcript) is the mRNA coding for NAF-1 [19].
Using in situ hybridization it was also shown that NAF-1 was over-
expressed in the brain. These ﬁndings revealed that Noxp70was strongly
expressed at embryonic day 15, in the ventricular zone around the telen-
cephalic ventricle, whereas lower expression was identiﬁed in the thala-
mus and hypothalamus. These results were ﬁrst to suggest NAF-1 as a
potentially important protein for neural development.The neurodegenerative disease Parkinson's (PD) affects about 1% of
the population over the age of 65. Mitochondrial integrity and function
were shown to be key factors inmaintaining normal, healthy cells, espe-
cially non-dividing ones, such as neurons. Recently, PARKIN, a causal
gene for autosomal recessive early-onset parkinsonism, has been dem-
onstrated to interact with mNT [84]. In several reports in which the dis-
cussion of possible drug targets for neurodegenerative diseases and CNS
injury were discussed in relation to mitochondrial dysfunction, mNT
was cited as a potential therapeutic approach for these diseases [81,
85,86].3.8. NAF-1 is involved in disease, the genetic disorder WFS2, and longevity
A recessive mutation in CISD2, the gene encoding NAF-1, located on
chromosome 4, leads to Wolfram Syndrome 2 (WFS2) [14,21,87]. This
mutation is a point mutation – guanosine is replaced by cytosine –
and as a result the second exon (out of three) in the NAF-1 pre-mRNA
is skipped. The skipping of exon 2 changes the reading frame and there-
by causes the formation of a premature termination codon in exon 3. In
themutatedmRNA75%of the protein sequence is not translated includ-
ing the iron–sulfur cluster binding domain (Fig. 16). WFS2 patients suf-
fer from diabetes, sight and hearing loss, nerve degeneration and a
severe bleeding tendency [14,21,87].
In addition, the region of chromosome 4, where the gene encoding
NAF-1 is located, hosts a number of genes associated with longevity
[87,88]. A constitutive over-expression of NAF-1 in transgenic mice de-
lays aging [89]. In contrast, knockout of NAF-1 in mice led to early aging
and general health problems such as blindness, distortion of the skele-
ton, bleeding and muscle and nerve degeneration. In addition, serious
damage to themitochondriawas observed alongwith an increase in au-
tophagy [22] (Fig. 17). The latter symptoms are similar to those seen in
WFS2 patients. Moreover, studies of NAF-1 knockout ﬁbroblasts
displayed ER stress and showed hallmarks of the unfolded protein re-
sponse [16]. The studies described above point to a central role for
Fig. 17. NAF-1 (Cisd2) mediates mitochondrial integrity and is essential for mammalian
life-span control. (A) The expression level of CISD2decreases in an age-dependentmanner
in naturally aged wild-type mice; there is an average 50% and 70% decrease in the 14–
16 months old and 26–28 months old mice, respectively, compared to 2–4 months old
young mice. In the wild-type mice, the mean life span is 25 ± 4 months. Partially
disintegrated mitochondria that accompany autophagy induction were detected in aged
mice. (B) In CISD2 knockout mice, the mitochondrial outer membrane seems to break
down prior to the destruction of the inner cristae. The damaged mitochondria appear to
induce autophagy in order to eliminate the dysfunctional organelles. Importantly, mito-
chondrial (Mt) breakdown exacerbates with age and autophagy increases in parallel to
the development of the premature aging phenotype in the Cisd2 knockout mice.
(C) Elevated levels of Cisd2 in transgenic mice or drug-stimulated expression in human
may ameliorate aging phenotypes such as muscle and neuronal tissue degeneration
and/or extend life span. Bearing in mind the evolutionary differences between rodents
and humans, the response to increased Cisd2 may be different (created based on Chen
et al. [22]).
Fig. 18. shRNA of NEETs and tumor proliferation. NAF-1 or mNT is required to support
tumor growth. Breast cancer cells (MDA-MB-231) with or without suppressed expression
of mNT (mNT−) or NAF-1 (NAF-1−) were injected subcutaneously (s.c.) into the back of
female CD1 nude mice, and tumor growth was monitored over time. (A) Slower tumor
growth of breast cancer cells (MDA-MB-231) with suppressed expression of mNT
(mNT−) or NAF-1 (NAF-1−) compared with control MDA-MB-231 cells. (B) Reduction
of mean tumor volume expressed as percentage of control MDA-MB-231 in mNT− or
NAF-1−MDA-MB-231 cells. (C and D) Images of representative tumors of each group ob-
tained at the end of the experiment. (E)Histological analyses of tumors usingH&E staining
showing large necrotic areas in tumors formed from controlMDA-MB-231 cells compared
with tumors formed from mNT− or NAF-1−MDA-MB-231 cells. *P b 0.05 [51].
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3.9. NEET proteins and cancer
Recently, a strong correlation was observed between the level of ex-
pression of NEET proteins and proliferation of various cancer cells, espe-
cially ones leading to the development of epithelial tumors. The
expression of NEET mRNA was found to be elevated in many different
types of cancer cells [90] with levels of mNT (CISD1) and NAF-1
(CISD2)mRNA expression elevatedmore than 40- and 140-fold, respec-
tively, in breast cancer compared to normal cells [91].
NAF-1 and mNT protein levels were determined in three different
epithelial breast cancer cell lines (MCF-7, MDA-MB-468 and HCC-70)
compared to a non-cancerous breast epithelial cell line (MCF-10a). A
substantial increase was found in the level of expression of NAF-1 inall cancerous cell lines and of mNT in two of the cancerous cell lines
[51]. These ﬁndings are supported by experiments that measured the
expression of mRNA encoding these NEET proteins in breast cancer
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age transformation and prevent autophagy in the mitochondria. They
also showed that constitutive over-expression of mNT in breast cancer
cells increases the size of the tumors developed from these cells [93].
We recently showed that knockdown of mNT or NAF-1 expression
using shRNA, a commonmethodology to determine the biological func-
tion of proteins, decreased cell proliferation and tumor development of
human epithelial breast cancer cells (Fig. 18) [51]. Several aspects ofmi-
tochondrial function were affected in cells with suppressed expression
of mNT or NAF-1. These included a decrease in membrane potential,
an increase in iron and ROS accumulation in mitochondria, a decrease
in aerobic respiration and an increase in glycolysis. In addition, cells
with suppressed expression of mNT or NAF-1 exhibited distorted
mitochondrial structure as evident by abnormal elongation and
loss of cristae (inner membranes) structures, and the accumulation
of autophagosomes [51]. The different effects of lower NEET expres-
sion on the mitochondrial structure and function are schematically
presented (Fig. 19), some of these, e.g. mitochondrial iron accumu-
lation, are consistent with phenotypes observed when the levels of
proteins involved in iron/iron–sulfur biogenesis and managements
are decreased [49,50]. The appearance of autophagosomes was
also accompanied by accumulation of proteins involved in autophagy
suggesting that this process was triggered in cells with reduced expres-
sion of mNT or NAF-1 [51].4. Outlook for the future of NEET protein research
NEET proteins such asmNT, NAF-1 and At-NEETwere shown to be in-
volved in many cellular processes, including calcium and iron homeosta-
sis, mitochondrial function,mitigation of oxidative stress, and autophagy/
apoptosis regulation [16,31,51,56]. Collectively these processes can affect
awide spectrumof cellular activities and improve the overall health of the
organism. Indeed, the involvement of NEET proteins in numerous human
diseases was described in detail in Section 2 above and is schematically
summarized in Fig. 20.Fig. 19.Mitochondrial function in cells with low expression of NEET proteins. Culture cells with
potential and an increase in the accumulation of iron and reactive oxygen species (ROS); determ
are mitigated by the addition of an iron chelator (red). Knockdown of mNT or NAF-1 also show
Seahorse Extracellular Flux Analyzer. Additionally, knockdowns showed mitochondrial phys
(green); measured using electron microscopy. Electron microscopy also revealed autophagoso
blots that showed an increase in the accumulation of autophagy markers (green and orange, rAlthough our knowledge of NEET protein structure–function rela-
tionship has improved signiﬁcantly since their discovery, many ques-
tions related to NEET protein function(s) remain unanswered. Among
them are: What proteins in the cell donate their 2Fe–2S clusters to
NEETproteins?What proteins accept their clusters fromNEETproteins?
What cellular transcripts, proteins and pathways respond to changes in
mNT and/or NAF-1 protein levels? What metabolic processes are regu-
lated by mNT and NAF-1? How do these processes change with the
redox state of the cell and/or environmental e.g. nutrient stress?
The outlook for future research on NEET proteins is therefore broad
and promising, andmuch remains to be learned about their biochemical
and biological function(s), as well as their relation to human health and
disease. One promising approach is the continued search for their cellu-
lar partners by experimental biochemical methodologies such as co-
immunoprecipitation pull-down methods [55], peptide arrays [58,94,
95], and yeast-2-hybrid assays [92]. These experimental approaches
could now be complemented by new and novel computational tech-
niques such as DCA, developed to identify and predict protein–protein
interactions with a goal of suggesting partner proteins. We believe
that the combination of experimental and computational techniques
will provide an unprecedented level of detail which could be exploited
for NEET protein investigations, as well as the design of therapies/
drugs for NEET-related diseases.
Another promising avenue of experimental research is the use of dif-
ferent “omics” tools such as transcriptomics, metabolomics and proteo-
mics. Thesemethods could be applied to cells with altered expression of
different NEET proteins, or to cells treated with different drugs that tar-
get NEET proteins, to identify and dissect the different pathways and
metabolites/genes/proteins that are affected or linked to NEET proteins
and their emerging interacting protein and metabolic networks.
Together, a synergy of experimental and theoretical approaches, as
well as the use of a systems biology approach, will lead to a mechanistic
understanding of NEET protein function in cells as well as their involve-
ment in different human pathologies. Some of the different platforms to
be used in future NEET research and their potential importance are
outlined below.decreased expression of NEET proteins (mNT− or NAF-1−) showed decrease inmembrane
ined frommitochondrial andROS selectiveﬂuorescencemeasurements. Thesephenomena
ed a decrease in aerobic respiration and increase glycolysis (purple); measured using the
iology distortions reﬂected in the abnormal progressive lengthening and loss of cristae
me accumulation in the knockdown cells. This interpretation was supported by western
espectively).
Fig. 20. Cellular localization, protein partners and function of theNEET proteinsmNT and NAF-1, and the human diseases they are involved in. A scheme summarizingmost of the research
ﬁndings pertained to the function of NEET proteins. Themechanismof cluster loss, resulting in cluster transfer or alternatively cluster dissociation is illustrated as one of the key features of
NEET protein function. This process leads in some cases to the enhanced generation of reactive oxygen species (ROS). Known putative protein partners and interacting molecules are
speciﬁed. Genetic disorders or other disruption of the function and/or alteration of the cellular protein level of mNT or NAF-1 is shown to lead to different diseases.
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Currently, the extent of changes to the global metabolite and gene
networks in cells with alteredNEET function is unknown.Metabolomics
and transcriptomics toolswill aid in characterizing the role of NEET pro-
teins in the cell by revealing how the cellular chemistry and gene ex-
pression proﬁle changes in response to NEET expression/modiﬁcation.
i. Role of the NEET proteins in cellular regulation: RNA-Seq studies
A cell's transcriptome comprises all of the expressed RNA sequences,
taking into account transcript structure, splicing and quantity.
Technologies developed to determine the transcriptome include
hybridization-based approaches, such as microarrays, and sequence-
based approaches known as RNA-sequencing (RNA-Seq) (reviewed
in [96,97]). Both technologies have been used extensively throughout
the study of human diseases to better understand the transcriptional
landscape of cellular aberrations [92,98–100]. Currently, RNA-Seq is
the preferred method for measuring a cell's transcriptome, since it is
able to measure absolute quantity of almost all transcripts in the cell,
it accounts for alternative splicing and alternative start and stop
sites, and it is able to detect different epigenetic regulatory mecha-
nisms [96].
As described above, NEET proteins appear to play multiple roles in
cells that could be dependent on speciﬁc cell function(s), energetic
programming and the state of the cellular environment. Examples
include the study of obesity in a model “pink” mice, the Wolframmodel mice, NEET suppression in breast cells and tumors, as well
as sustained longevity in NAF-1 overexpressing mice [9,16,19,22,
51,64,73,81,83,85,86,89,100,101]. NAF-1 and mNT are implicated
in affecting iron and calcium homeostasis, ROS accumulation and
oxidative capacity, all of which are known effectors of nuclear and
mitochondrial gene expression. RNA-Seq would be a key tool in de-
termining whether NEET proteins directly activate/deactivate tran-
scriptional regulators or alter the cellular environment triggering
changes in gene expression. This information will aid in gaining a
greater understanding of the speciﬁc mechanisms of NEET protein
function.
ii. Role of the NEET proteins in cellular biochemistry: Metabolomics
studies
Metabolomics is the study of metabolites accumulated in cells during
different cellular processes.Metabolic proﬁling in a clinical or research
setting, consisting of chromatography, ionization andmass spectrom-
etry tools, hasmany applications, including determining the complete
chemical proﬁle of a cell or tissue, identifying altered proteins and
protein complexes, and discovering and screening for disease-
related chemical biomarkers in tissue and ﬂuid samples. There are
many excellent reviews discussing metabolic proﬁling tools, their
application to analyzing human disease states and bioinformatics re-
sources (review examples— [102–106]). NAF-1 andmNT are capable
of transferring Fe–S clusters to recipient protein(s), possibly altering
function, participate in iron and calcium homeostasis, cause energetic
reprogramming and play a role in regulation of oxidative stress and
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is likely to cause changes in cells resulting in perturbations in cellular
chemistry in cells with altered NEET protein expression. Metabolo-
mics analysis will assist in understanding those perturbations. Several
studies have used various metabolic proﬁling tools to analyze path-
ways related to diseases characterized by ER stress andmitochondrial
dysfunction. Cross-referencing data drawn from related ER, mito-
chondria, oxidative stress and cancer studieswithNEET speciﬁcmeta-
bolomics will support efforts to understand complex phenotypes
observed in cells defective in NEET function.
Taken together,metabolomics and transcriptomics data yields amuch
more comprehensive snapshot of what is happening in the cell than
either one alone. These coupled with proteomics tools will be instru-
mental in the future characterization of NEET proteins.
4.2. Protein–protein interactions: further development of DCA
The recent study of Tamir et al. [58] on the molecular interactions
between Bcl-2 and the NEET protein NAF-1 clearly demonstrated the
power of integrated experimental and theoretical approaches. In the lat-
ter, the DCA method was applied. This methodology has been useful to
uncover pairwise amino acid dependencies, created through the course
of evolution, which are embedded in sequences belonging to a protein
family. These dependencies or couplings were shown to be a proxy of
physical interactions among residue pairs within a protein [107]. Al-
though intradomain residue–residue interactions is the most likely cat-
egory of coupled sites, some very interesting exceptions were revealed
which captured residue contacts, arising from alternative protein
conformations, ligand-mediated residue couplings, and interdomain in-
teractions in protein oligomers [107]. This methodology has been suc-
cessful in the area of protein structure prediction [108,109] and has
been useful to uncover conformational diversity in proteins [110,111].
However, its application to protein interactions seems to bemore prom-
ising and already has shown interesting results [58,112,113]. DCA for
protein interactions advances the idea that, just as in the case of intra-
protein residue interactions, important inter-protein residue interac-
tions coevolved and are maintained during evolution. As spontaneous
changes occur in one partner protein, there exists an evolutionary
drive to revert or select for compensatory changes on the partner pro-
tein. Information on these compensatory changes is contained within
the sequences of protein domains in the diversity of nature. For the
Bcl-2–NAF-1 interaction a few highly ranked couplings were structural-
ly distant from themajority suggesting possible allosteric effects, which
had previously been noted in that region of the protein [42].
To uncover the interaction network of NEET proteins, DCA could be
used to propose interactions based on the ever-increasing availability
of genomic sequences. The method could potentially identify key inter-
action sites between NAF-1 and other partner proteins, as well as be-
tween mNT and their partner proteins. These key interactions can be
combined with molecular dynamics simulations such as Structure
Based Models (SBM) [114,115] to predict high-resolution complex
structures and identify important interaction interfaces. The use of
DCA to study protein interactions in the NEET pathway is not limited
to ﬁnding key interactions; the power of this theoretical tool also lies
in the ability to do in silicomutagenesis in theproposed interactingpart-
ners and has a quantitative estimate of its effect on the interaction. An
example of this for the case of two-component systems is documented
in [113]. This strategy could potentially be used in the design of drugs or
therapies directed at altering the interactions of NEET proteinswith dif-
ferent cellular targets.
5. Summary
MitoNEET, originally identiﬁed as the mitochondrial target of the
anti-diabetic TZD class of drugs, is the founding member of a small but
distinct class of human redox active 2Fe–2S proteins, the NEET family.Representativemembers of NEET proteinswere found inmost other or-
ganisms, including archea, bacteria, algae, and plants demonstrating an
evolutionary-conserved function. Biochemical and biophysical charac-
terization showed that NEET proteins have unique properties that in-
clude a novel structure and ability to tune the redox potential of their
clusters, a rare capability to transfer their 2Fe–2S clusters to other pro-
teins, and a potential to transfer their cluster/iron to the mitochondria
or chloroplast. Functional analysis in different biological systems dem-
onstrated a role for NEET proteins in the regulation of ROS and iron ho-
meostasis. Accordingly, misregulation or knockdown of these proteins
leads to various health issues and missplicing of NAF-1 is a causative
of Wolfram Syndrome 2. Both mNT and NAF-1 were found to be
“enslaved” proteins in breast cancer cells, supporting cell proliferation
and enhancing mitochondrial function of cancer cells. Knockdown of
these proteins was therefore found to decrease growth of tumors in
mice models. MitoNEET was found to associate with several proteins,
includingGDH1,whichmight linkmNTback to its original identiﬁcation
as an anti-diabetic drug target. In addition, mNT was recently proposed
to be involved in iron–sulfur biogenesis and trafﬁcking [116]. NAF-1 as-
sociations with a distinct set of proteins include Bcl-2 linking NAF-1 to
longevity, autophagy and apoptosis. Recently, genetic studies in Drosoph-
ila and human cells suggested two novel proteins (PPT1 and CLN3) as
interactors of NAF-1 (CISD2) [88]. The ability to transfer the 2Fe–2S clus-
ter in its entirety and without loss has only been observed in proteins in-
volved in cluster assembly or transfer. Therefore, the ﬁndings that mNT
and NAF-1 can satisfy those conditions suggest their involvement in clus-
ter assembly/transfer processes, yet the physiological NEET cluster donor
as well as apo-acceptors protein(s) need to be identiﬁed. Moreover, how
is the function of cluster transfer related to the many diseases associated
with NEET proteins is a subject for future investigations.
Although much has been learned over the decade about NEET pro-
teins, as described above, many questions remain unanswered. We be-
lieve that a combination of several different complementary platforms
that include theoretical, computational and experimental techniques
will be needed to decipher the full range of biological functions and
partner proteins associated with NEET proteins. Such an understanding
will lead to the development of new drugs that target these important
proteins and improve our chances of ﬁghting several major health con-
ditions such as cancer, diabetes, obesity and longevity, linked to NEET
proteins.
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